STAMA PRO- lidocaine spray 
Cerno Pharmaceuticals

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

ACTIVE INGREDIENT

Each milliliter contains
 Active Ingredient Purpose
 Lidocaine Hydrochloride 9.6% Male Genital Desensitizer

INACTIVE INGREDIENT

Methylparaben, Propylparaben, Carboxymethyl Cellulose Sodium, Deionized Water.

KEEP OUT OF REACH OF CHILDREN

If swallowed, get medical help or contact a Poison Control Center.

INDICATIONS & USAGE

Helps in the prevention of premature ejaculation.

WARNINGS

For external use only. ■ Avoid contact with the eyes.

Stop use and ask a doctor:

■ If you or your partner develop a rash or irritation such as burning or itching. If symptoms persist, consult a doctor.

■ Premature ejaculation may be due to a condition requiring medical supervision. If this product, used as directed does not provide relief, discontinue use and consult a doctor.

DOSAGE & ADMINISTRATION

Remove the protective cap. Press the actuator down repeatedly until product dispenses to prime spray pump.
Apply 3 or more sprays, not to exceed 10, to head and shaft of penis 8 minutes before intercourse, or use as directed by a
doctor. Wash product off after intercourse. After spraying, place the cap back on.

PURPOSE

Male Genital Desensitizer

Other Information

■ Keep away from fire and flames. ■ Store at 20-25°C (68-77°F)

Made in the U.S.A.

Label Image
STAMA PRO 
lidocaine spray
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70107-302
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE96 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
CARBOXYMETHYLCELLULOSE (UNII: 05JZI7B19X)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70107-302-0913.5 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product01/11/2017
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34801/11/2017
Labeler - Cerno Pharmaceuticals (079821037)
Establishment
NameAddressID/FEIBusiness Operations
Cerno Pharmaceuticals079821037MANUFACTURE(70107-302)

Revised: 1/2017
Document Id: c38030a1-faaf-432d-ae2a-ab6a26e53978
Set id: 19f01eb1-e9f0-447b-af94-91efc6e99aa6
Version: 2
Effective Time: 20170111
 
Cerno Pharmaceuticals